✦ LIBER ✦

P1.026 Cognitive proflle and mild cognitive impairment (MCI) in Parkinson's disease: baseline data from the PROMS-PD cohort

✍ Scribed by D. Whitehead; A. Simpson; C. Hurt; D. Burn; J. Hindle; S. Landau; M. Samuel; K. Wilson; R.G. Brown

Book ID: 117753352
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 58 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70148-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1.185 Worry in Parkinson's disease: bas

P1.185 Worry in Parkinson's disease: baseline data from the PROMS-PD cohort

✍ D. Whitehead; A. Simpson; C. Hurt; D. Burn; J. Hindle; S. Landau; M. Samuel; K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

MDS task force on mild cognitive impairm

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI

✍ Irene Litvan; Dag Aarsland; Charles H. Adler; Jennifer G. Goldman; Jaime Kulisev 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

## Abstract There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson's disease–mil

Cerebrospinal fluid (CSF) biomarkers in

Cerebrospinal fluid (CSF) biomarkers in Alzheimer's disease (AD), mild cognitively impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort

✍ Judith Siuciak; Eve H. Pickering; Fred Immermann; Max Kuhn; Leslie Shaw; William 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

The placebo data analysis in Alzheimer's

The placebo data analysis in Alzheimer's disease and mild cognitive impairment (MCI) clinical trials project: Overview of progress in trial data collection, and key findings from the pooled MCI trial datasets

✍ Aisen, Paul; Thomas, Ronald; Carrillo, Maria; Mohs, Richard; Petersen, Ronald; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The epidemiology of mild cognitive impai

The epidemiology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg

✍ Magali Perquin, Anne-Marie Schuller, Michel Vaillant, Nico Diederich, Alexandre 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 346 KB

Cerebrospinal fluid (CSF) vs. plasma-bas

Cerebrospinal fluid (CSF) vs. plasma-based biomarkers in Alzheimer's disease (AD), mild cognitive impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort

✍ William Potter; Eve H. Pickering; Fred Immermann; Max Kuhn; Judith Siuciak; Lesl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB